India, Sept. 12 -- HAB Pharmaceuticals & Research Limited (HAB Pharma), an Indian pharmaceutical company with a legacy spanning over four decades, has appointed Pankaj Agarwal as Chief Financial Officer (CFO). The appointment comes as HAB Pharma strengthens its financial and organisational capabilities to support its next phase of growth, driven by expanding manufacturing capacities, R&D initiatives, domestic presence and international market opportunities.

A Chartered Accountant with almost 18 years of experience across the healthcare and pharmaceutical sectors, Agarwal brings expertise in financial strategy, planning and forecasting, financial reporting and compliance, fundraising, treasury management, audit, risk assessment and operat...